| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/09/2005 | CN1575821A Hemostatic devices and methods of making same |
| 02/09/2005 | CN1575819A Use of melanoma differentiation associated gene (mda-7) for reversing cancerous phenotype |
| 02/09/2005 | CN1575817A Gamma-aminobutyric acid derivatives containing, solid compositions and process for preparing the same |
| 02/09/2005 | CN1575816A Compounds for the treatment of female sexual dysfunction |
| 02/09/2005 | CN1575813A Preparation for eyes and preparing method thereof |
| 02/09/2005 | CN1575802A Composition for suppressing blood sugar ascending |
| 02/09/2005 | CN1575800A Application of astragalus root polysaccharide in preparation of antilipemic agent and health products |
| 02/09/2005 | CN1575799A Application of Artemisia sphaerocephala Krasch polysaccharide in prrparation of antilipemic agent and health products |
| 02/09/2005 | CN1575798A Rapid disintegration and rapid dissolution tablet containing kakonein |
| 02/09/2005 | CN1575797A New use of medicine containing escin and its salt |
| 02/09/2005 | CN1575796A Ligustrazine phosphate dripping pill and preparation thereof |
| 02/09/2005 | CN1575795A Naloxone hydrochloride nasal spray |
| 02/09/2005 | CN1575794A Liquid prepartion containing rosickyite imidazole sulfoxide |
| 02/09/2005 | CN1575793A Functional chewing gum composition for improving effectively obesity and blood fat |
| 02/09/2005 | CN1575656A 杀微生物的组合物 The composition of microorganisms kill |
| 02/09/2005 | CN1188428C 6-mercapto-cyclodextrin derivs medical composition containing the same derivs and use thereof |
| 02/09/2005 | CN1188422C Calcium (3S) tetrahydro-3-furanyl (1S, 2R)-3-[[(4-aminophenyl)sulfonyl] (isobutyl) amino]-1-benzyl-2-(phosphonooxy) Propylcarbamate |
| 02/09/2005 | CN1188418C Cephalosporines having cyclic aminoguanidine substituents as antibiotics |
| 02/09/2005 | CN1188417C 3,6-disubstituted penam sulfone derivatives as antibacteriuls |
| 02/09/2005 | CN1188416C Oxathiepino [6,5-b]dihydropyridines,and related compositions and preparation methods |
| 02/09/2005 | CN1188415C Pyrazolopyrimidinones which inhibit type 5 cyclic guanosine 3', 5'-monophosphate phosphodiesterase (cGMP PDE5)for treatment of sexual dysfunction |
| 02/09/2005 | CN1188413C Compound for treatment of pain |
| 02/09/2005 | CN1188412C Process for preparing crystalline form 1 of cabergoline |
| 02/09/2005 | CN1188410C Nonsteroid IL-5 inhibitor, its preparation method and medical composition containing the same inhibitor |
| 02/09/2005 | CN1188409C Stereoisomeric indole compounds, process for preparation of same and use thereof |
| 02/09/2005 | CN1188407C Imidazole derivatives with farnesyl transferase to inhibite activity and preparing method thereof |
| 02/09/2005 | CN1188406C Cattail pollen extract and preparation process and use thereof |
| 02/09/2005 | CN1188405C New Morpholinobenzamide salts |
| 02/09/2005 | CN1188404C Cyclic compound |
| 02/09/2005 | CN1188403C Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 02/09/2005 | CN1188402C Piperazinone derivs. and their uses |
| 02/09/2005 | CN1188394C N-substituted-N'-substituted urea derivative and medicinal compositions containing the same |
| 02/09/2005 | CN1188389C Benzamide derivatives for the treatment of diseases caused by cytokines |
| 02/09/2005 | CN1188388C Aminobenzophenones as inhibitors of interleukin and TNF |
| 02/09/2005 | CN1188258C Process for high polymer synthesis to phenol compounds and the use thereof |
| 02/09/2005 | CN1188189C Transdermal patch substrate containing 17-deacetyl norgestimate and use of substrate |
| 02/09/2005 | CN1188176C Coating useful as dispenser of active ingredient no dressings and bandages |
| 02/09/2005 | CN1188170C Solution comprising prostaglandins and benzyl alcohol |
| 02/09/2005 | CN1188157C Chinese herbal medicine tumor-eliminating drop |
| 02/09/2005 | CN1188154C Quick-acting antalgesic-antipruritic tincture and preparing method thereof |
| 02/09/2005 | CN1188151C Analgesic injection |
| 02/09/2005 | CN1188148C Process for preparing staltic-antagic medicine to treat trauma |
| 02/09/2005 | CN1188145C Medicine for curing tuberculosis and preparing method |
| 02/09/2005 | CN1188141C Use of ginkgo biloba extracts for preparing a medicine |
| 02/09/2005 | CN1188138C Use of refind fur-seal oil in medicine for preventing and treating climacteric metancholia and menalgia |
| 02/09/2005 | CN1188137C Use of erythrogenin and molecule with active EPO receptor ability or analog EPO activation in pharmacy |
| 02/09/2005 | CN1188136C Buffered composition for dialysis |
| 02/09/2005 | CN1188135C Nutrient tablet for sobering and protecting liver |
| 02/09/2005 | CN1188134C Preparation having increased in vivo tolerability |
| 02/09/2005 | CN1188132C Medicine for inhibiting and killing body's superficial pathogenic fungi |
| 02/09/2005 | CN1188131C Orally taken pulsed releasing system of phenyl diazepine medicine and its prepn |
| 02/09/2005 | CN1188130C Quetiapine granules |
| 02/09/2005 | CN1188129C Pectoral |
| 02/09/2005 | CN1188128C Triazineone compounds for treating diseases due to sarcosystis neospora and toxoplasma |
| 02/09/2005 | CN1188127C Nasal cavity administrated prepn for treating cerebral tumor |
| 02/09/2005 | CN1188126C Preparation of compound Famotine dispersant pills |
| 02/09/2005 | CN1188125C Use of 2-imidazoly substituted carbinols for production of medicament for treatment or prophylaxis of disease states as result of ischaemic conditions |
| 02/09/2005 | CN1188124C Process for preparing ginkgolide injection |
| 02/09/2005 | CN1188123C Novel use of (R)-(-)-2-[5-(4-fluorophenyl)-3-pyridylmethylamino methyl]-benzodihydropyran and its physiologically acceptable salts |
| 02/09/2005 | CN1188122C 新制剂 The new formulation |
| 02/09/2005 | CN1188121C Therapeutic substituted guanidines |
| 02/09/2005 | CN1188120C Method for treating eating disorders |
| 02/09/2005 | CN1188119C Method of reducing appearance of black colour at lower part of eye |
| 02/09/2005 | CN1188118C Medicine for preventing or treating cancer and its usage |
| 02/09/2005 | CN1188117C Application of 1, 3-diphenyl-1, 3-propanedione in preparing medicine for treating hepatitis |
| 02/09/2005 | CN1188113C Pharmaceutical mixture comprising a combination of a profen and other active compounds |
| 02/09/2005 | CN1188112C Production process of polymerized micelle with injected medicine and polymerized micelle composition |
| 02/09/2005 | CN1188111C Dry powder compositions having improved dispersivity |
| 02/09/2005 | CN1188106C Oral compsn. comprising 2'-hydroxypropiophenone |
| 02/08/2005 | US6852889 Antioxidant nitroxides and nitrones as therapeutic agents |
| 02/08/2005 | US6852882 N-(2-(N-formyl-N-hydroxyamino)ethyl)arylamides with bacterial polypeptide deformylase inhibiting activity |
| 02/08/2005 | US6852870 Omega-3 fatty acids in the treatment of depression |
| 02/08/2005 | US6852863 Osteoporosis; immunosuppressants; wound healing agent |
| 02/08/2005 | US6852861 Preparation of 1H-imidazo [4,5-C] quinolin-4-amines via 1H-imidazo [4,5-C] quinolin-4-phthalimide intermediates |
| 02/08/2005 | US6852839 Fhm, a novel member of the TNF ligand supergene family |
| 02/08/2005 | US6852838 Nucleotide sequences coding polypeptide for use in the treatment of muscular disorders |
| 02/08/2005 | US6852818 Molecularly imprinted polymers produced by template polymerization |
| 02/08/2005 | US6852758 For oral medicinal formulations and foods |
| 02/08/2005 | US6852757 Isomer enriched conjugated linoleic acid compositions |
| 02/08/2005 | US6852756 Use of pleuromutilin derivatives for transdermal treatment of bacterial diseases |
| 02/08/2005 | US6852755 This invention pertains to nitrogen mustard compounds (Formula (II)) and prodrugs therefor (Formula (I)), methods for their preparation, pharmaceutical compositions comprising such compounds, and the use of such compounds and |
| 02/08/2005 | US6852753 Treating hyperlipidemic condition, gallstones |
| 02/08/2005 | US6852751 Difluorobutyric acid metalloprotease inhibitors |
| 02/08/2005 | US6852749 Pyrazolidinol compounds |
| 02/08/2005 | US6852748 Derivatives of 6,7-dihydro-5H-imidazo(1,2- alpha )imidazole-3- sulfonyl)-pyrrolidine-2-carboxylic acid amide which exhibit good inhibitory effect upon the interaction of CAMs and Leukointegrins and are thus useful in the treatment |
| 02/08/2005 | US6852747 Resorcinol derivatives |
| 02/08/2005 | US6852746 6-((2,2- diphenylethyl)amino)-9-(N-ethyl- beta -D-ribofuranosyluronamide)-N--(2-(N'-(1-(2-pyridyl)-4 -piperidyl)ureido)ethyl)-9H-purine-2-carboxamide |
| 02/08/2005 | US6852743 Preventives for the recurrence of cerebrovascular failure and agents for ameliorating troubles following cerebrovascular failure and inhibiting progress thereof |
| 02/08/2005 | US6852742 To modulate the activity of calcium channels, therapy of cardiovascular disease or neurological disorders, that are associated with calcium channels |
| 02/08/2005 | US6852741 Compositions and methods for treatment of neurological disorders |
| 02/08/2005 | US6852740 Treating p38 kinase mediated disorders. Compounds of particular interest are defined by Formula I Mitogen-activated protein kinases (MAP) is a family of proline- directed serine/threonine kinases that activate their |
| 02/08/2005 | US6852739 Novel nitrosated and/or nitrosylated proton pump inhibitor compounds, and novel compositions comprising at least one proton pump inhibitor compound that is optionally substituted with at least one NO and/or N02 group, and, optionally, at |
| 02/08/2005 | US6852738 Potent ligands for PPAR gamma and generally have antagonist or partial agonist activity. The compoundsare for treatment, control or prevention of obesity, non-insulin dependent diabetes mellitus (NIDDM), hyperglycemia, dyslipidemia, |
| 02/08/2005 | US6852736 Phenoxypropanolamines, preparation and therapeutic use thereof |
| 02/08/2005 | US6852734 Indole wherein A is an oxygen atom or a nitrogen atom which nitrogen atom is optionally substituted with an alkyl group, and (i) R1 and R2 each stand for a hydrogen atom or an alkyl group, independently, or (ii) R1 and R2 as taken together form |
| 02/08/2005 | US6852732 A tetrahydropyridino or piperidino heterocyclic derivative represented by the formula (I): has a high affinity for CRF receptors and is effective against diseases in which CRF is considered to be involved. (Corticotropin releasing factor |
| 02/08/2005 | US6852731 3-Substituted-7-oxo-4,7-dihydro-thieno(3,2-b)pyridine-6-carboxylic acid benzylamide derivatives; for herpes viruses |
| 02/08/2005 | US6852730 Substituted fused pyrazolecarboxylic acid arylamides and related compounds |
| 02/08/2005 | US6852729 Macrolides |
| 02/08/2005 | US6852727 Inhibitors of Janus protein tyrosine kinases (Jak), and as such are useful as immunosuppressants, and in the treatment of diseases including asthma, allergies, autoimmune diseases. |